Synthesis, Molecular Modeling Studies, and Muscarinic Receptor Activity of Azaprophen Analogues

Journal of Medicinal Chemistry

Volumn 34, Issue 11, 1991, Pages 3164-3171

  Triggle, David J ^a   Kwon, Yong Who ^a   Abraham, Philip ^b   Pitner, J Bruce ^b   Mascarella, S Wayne ^b   Carroll, F I ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 AZABICYCLO[3.2.1]OCTANE DERIVATIVE; ACETIC ACID 6 (1 PHENYLETHYL) 6 AZABICYCLO[3.2.1]OCTAN 3ALPHA YL ESTER; ATROPINE; AZAPROPHEN; AZAPROPHEN DERIVATIVE; CARBACHOL; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; OXOTREMORINE; PILOCARPINE; PIRENZEPINE; QUINUCLIDINYL BENZILATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CHO CELL; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; HEART; ILEUM; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION;

ANIMAL; BINDING, COMPETITIVE; CRICETULUS; FEMALE; GUINEA PIGS; HAMSTERS; MALE; MODELS, MOLECULAR; MUSCLE, SMOOTH; RADIOLIGAND ASSAY; RATS; RATS, INBRED STRAINS; RECEPTORS, MUSCARINIC; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, U.S. GOV'T, P.H.S.; TROPANES;

EID: 0026318360     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00115a003     Document Type: Article

References (23)

1. Perry, E. K. The Cholinergic Hypothesis Ten Years On. Br. Med. Bull. 1986, 42 (1), 63-69.
2. Giacobini, E.; Becker, R. (Eds.) Current Research in Alzheimer Therapy; Taylor and Francis: New York, 1988.
3. Moos, W. H.; Davis, R. E.; Schwarz, R. D.; Gamzu, E. R. Cognition Activators. Med. Res. Rev. 1988, 8 (3), 353-369.
4. Becker, R. E.; Giacobini, E. Mechanisms of Cholinesterase Inhibition in Senile Dementia of the Alzheimer Type: Clinical, Pharmacological, and Therapeutic Aspects. Drug Dev. Res. 1988, 12 (3-4), 163-195.
5. Wettstein, A.; Speigel, R. Clinical Trials with the Cholinergic Drug R586-Alzheimer's Disease (AD) and Senile Dementia of the Alzheimer Type (SDAT). Psychopharmacology 1984, 84, 572-573.
6. Levine, R. R.; Birdsall, N. J. M. (Eds.) Subtypes of Muscarinic Receptors. IV. Trends Pharmacol. Sci. Suppl. 1989, December.
7. Hammer, R.; Berrie, C. P.; Birdsall, N. J. M.; Burgen, A. S. V.; Hulme, E. C. Pirenzepine Distinguishes between Different Subclasses of Muscarinic Receptors. Nature 1980, 283, 90-92.
8. Brown, E.; Kendall, D. A.; Nahorski, S. R. Inositol Phospholipid Hydrolysis in Rat Cerebral Cortical Slices: 1. Receptor Characterization. J. Neurochem. 1984, 42 (5), 1379-1387.
9. Fisher, S. K.; Bartus, R. T. Regional Differences in the Coupling of Muscarinic Receptors to Inositol Phospholipid Hy-drolysis in Guinea Pig Brain. J. Neurochem. 1985, 45, 1085-1095.
10. Hollander, E.; Mohs, R. C.; Davis, K. L. Cholinergic Approaches to the Treatment of Alzheimer's Disease. Br. Med. Bull. 1986, 42, 97-100.
11. Saunders, J.; Cassidy, M.; Freedman, S. B.; Harley, E. A.; Iversen, L. L.; Kneen, C.; McLeod, A. M.; Merchant, K. J.; Snow, R. J.; Baker, R. Novel Quinuclidine-Based Ligands for the Muscarinic Cholinergic Receptor. J. Med. Chem. 1990, 33, 1128-1138.
12. Carroll, F. I.; Abraham, P.; Parham, K.; Griffith, R. C.; Ahmad, A.; Richard, M. M.; Padilla, F. N.; Witkin, J. M.; Chiang, P. C. 6-Methyl-6-azabicyclo[3. 2. 1]octan-3α-ol 2, 2-Diphenyl-propionate (Azaprophen), a Highly Potent Antimuscarinic Agent. J. Med. Chem. 1987, 30, 805-809.
13. rmuscarinic Acetylcholine Receptors: Conserved Aspartic Acids Play Important Roles in Receptor Function. Mol. Pharmacol. 1990, 36 (6), 840-847.
14. Freedman, S. B.; Harley, E. A.; Iversen, L. L. Relative Affinities of Drugs Acting at Cholinoceptors in Displacing Agonist and Antagonist Radioligands: the NMS/Oxo-M Ratio as an Index of Efficacy at Cortical Muscarinic Receptors. Br. J. Pharmacol. 1988, 93 (2), 437-445.
15. Pitner, J. B.; Abraham, P.; Joo, Y. J.; Triggle, D. J.; Carroll, F. I. Synthesis and Stereoselective Reduction of (±)-, (+)-, and (-)-6-Substituted-6-azabicyclo[3. 2. 1]octan-3-one. J. Chem. Soc., Perkin Trans. 1 1991, 1375-1381.
16. Rosenberger, L. B.; Triggle, D. J. Calcium Ion Utilization in Guinea Pig Ileal Longitudinal Smooth Muscle in Response to a Series of Muscarinic Agonists. Can. J. Physiol. Pharmacol. 1979, 57 (12), 1375-1380.
17. Clark, M.; Cramer, R. D.; Van Opdenbosh, N. Validation of the General Purpose Tripos 5. 2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
18. M. Clark. Tripos Force Field Modification for Aromatic Rings. SYBYL Update Newsl. 1990, 3 (1), 11-12.
19. 3H]Nitrendipine, to Guinea-Pig Ileal Smooth Muscle. J. Pharmacol. Exp. Ther. 1983, 225, 291-310.
20. ++Channel Agonist Bay K 8644. J. Pharmacol. Exp. Ther. 1984, 231, 8-15.
21. 3H]-Labeled Antagonist Competition. Can. J. Physiol. Pharmacol. 1982, 60, 1707-1714.
22. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-dye Binding. Anal. Biochem. 1976, 72, 248-253.
23. 50) of an Enzymatic Reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.